Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
A1C & T2D Control: Tirzepatide -2.3% vs -1.8% For type 2 diabetes management, tirzepatide met superiority over semaglutide across all doses in the SURPASS-2 trial
/ month $135.00 Original price was: $135.00.$75.00Current price is: $75.00
Consider Hormone Replacement Therapy (HRT) NICE Menopause Guidelines recommend HRT for vasomotor symptoms
We hope this approval supports increasing access to obesity care in the UK. The pills, which contain semaglutide, are now approved for adults who are obese (BMI of 30 or above) or overweight (BMI of 27-30) and have at least one weight-related health condition
US$ 26.04
US$ 28.53
US$ 29.18
